Accuray and UW-Madison Sign 10-Year Research Agreement for Adaptive Cancer Therapy

Accuray Incorporated and the University of Wisconsin School of Medicine and Public Health have entered a 10-year research agreement to advance personalized cancer treatments using Accuray's Stellar adaptive radiation therapy platform, announced in a press release.

The collaboration will focus on clinical research, education, and the development of adaptive therapies that support precision cancer care. It formalizes a long-standing relationship between Accuray and the university, which began with the creation of the TomoTherapy System in the late 1980s. That system integrated helical 3D image guidance with intensity modulated radiation therapy, improving accuracy in treatment delivery.

According to the announcement, this new agreement will build on that history to develop future adaptive radiotherapy technologies and training programs aimed at improving patient outcomes and advancing clinical practice in radiation medicine.